PDB Short entry for 2HAG HEADER HYDROLASE 12-JUN-06 2HAG TITLE CRYSTAL STRUCTURE OF A PUTATIVE DYP-TYPE PEROXIDASE PROTEIN (SO_0740) TITLE 2 FROM SHEWANELLA ONEIDENSIS AT 2.75 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: MELANIN BIOSYNTHESIS PROTEIN TYRA, PUTATIVE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SHEWANELLA ONEIDENSIS; SOURCE 3 ORGANISM_TAXID: 70863; SOURCE 4 GENE: NP_716371.1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS FERREDOXIN-LIKE FOLD, STRUCTURAL GENOMICS, JOINT CENTER FOR KEYWDS 2 STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, KEYWDS 3 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 25-JAN-23 2HAG 1 SEQADV LINK REVDAT 5 18-OCT-17 2HAG 1 REMARK REVDAT 4 13-JUL-11 2HAG 1 VERSN REVDAT 3 23-MAR-11 2HAG 1 HEADER TITLE KEYWDS REVDAT 2 30-DEC-08 2HAG 1 JRNL VERSN REVDAT 1 08-AUG-06 2HAG 0 JRNL AUTH C.ZUBIETA,S.S.KRISHNA,M.KAPOOR,P.KOZBIAL,D.MCMULLAN, JRNL AUTH 2 H.L.AXELROD,M.D.MILLER,P.ABDUBEK,E.AMBING,T.ASTAKHOVA, JRNL AUTH 3 D.CARLTON,H.J.CHIU,T.CLAYTON,M.C.DELLER,L.DUAN,M.A.ELSLIGER, JRNL AUTH 4 J.FEUERHELM,S.K.GRZECHNIK,J.HALE,E.HAMPTON,G.W.HAN, JRNL AUTH 5 L.JAROSZEWSKI,K.K.JIN,H.E.KLOCK,M.W.KNUTH,A.KUMAR, JRNL AUTH 6 D.MARCIANO,A.T.MORSE,E.NIGOGHOSSIAN,L.OKACH,S.OOMMACHEN, JRNL AUTH 7 R.REYES,C.L.RIFE,P.SCHIMMEL,H.VAN DEN BEDEM,D.WEEKES, JRNL AUTH 8 A.WHITE,Q.XU,K.O.HODGSON,J.WOOLEY,A.M.DEACON,A.GODZIK, JRNL AUTH 9 S.A.LESLEY,I.A.WILSON JRNL TITL CRYSTAL STRUCTURES OF TWO NOVEL DYE-DECOLORIZING PEROXIDASES JRNL TITL 2 REVEAL A BETA-BARREL FOLD WITH A CONSERVED HEME-BINDING JRNL TITL 3 MOTIF. JRNL REF PROTEINS V. 69 223 2007 JRNL REFN ISSN 0887-3585 JRNL PMID 17654545 JRNL DOI 10.1002/PROT.21550 REMARK 2 REMARK 2 RESOLUTION. 2.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.54 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 13888 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 691 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.82 REMARK 3 REFLECTION IN BIN (WORKING SET) : 953 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.11 REMARK 3 BIN R VALUE (WORKING SET) : 0.3400 REMARK 3 BIN FREE R VALUE SET COUNT : 54 REMARK 3 BIN FREE R VALUE : 0.3750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2453 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 48 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 58.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.00000 REMARK 3 B22 (A**2) : -2.00000 REMARK 3 B33 (A**2) : 3.99000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.474 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.279 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.213 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 22.648 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2513 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2179 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3394 ; 1.134 ; 1.947 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5081 ; 0.615 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 306 ; 6.927 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 133 ;35.040 ;24.361 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 424 ;15.824 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;12.404 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 352 ; 0.063 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2843 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 526 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 600 ; 0.228 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2312 ; 0.212 ; 0.300 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1241 ; 0.198 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): 1414 ; 0.093 ; 0.500 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 130 ; 0.146 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 9 ; 0.146 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): 32 ; 0.215 ; 0.300 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.203 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1578 ; 2.670 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 622 ; 0.532 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2452 ; 3.803 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1064 ; 2.574 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 942 ; 3.761 ; 5.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 5 A 311 REMARK 3 ORIGIN FOR THE GROUP (A): 27.6410 27.5140 38.5230 REMARK 3 T TENSOR REMARK 3 T11: -0.0295 T22: -0.0528 REMARK 3 T33: -0.2081 T12: -0.0812 REMARK 3 T13: 0.0601 T23: 0.0299 REMARK 3 L TENSOR REMARK 3 L11: 1.3060 L22: 2.2233 REMARK 3 L33: 2.4529 L12: -0.3974 REMARK 3 L13: -0.1321 L23: -0.2717 REMARK 3 S TENSOR REMARK 3 S11: 0.0486 S12: 0.3797 S13: 0.1498 REMARK 3 S21: -0.3947 S22: -0.1279 S23: -0.1833 REMARK 3 S31: -0.0518 S32: 0.1326 S33: 0.0794 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.7 REMARK 3 TO ACCOUNT FOR THE REDUCED SCATTERING DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 3. ADDITIONAL ELECTRON DENSITY WAS NOTED ADJACENT REMARK 3 TO RESIDUE A20 BUT NOT MODELLED. 4. ATOM RECORD CONTAINS REMARK 3 RESIDUAL B FACTORS ONLY. REMARK 4 REMARK 4 2HAG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000038131. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979291, 0.918370, 0.978940 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 MONOCHROMATOR (HORIZONTAL REMARK 200 FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13932 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 29.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.10700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.8500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.83500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE, RESOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: AFTER THE INITIAL TRACE, A MODEL OF A HOMOLOGOUS REMARK 200 PROTEIN (PDB ENTRY 2GVK) WAS USED TO FACILITATE REMARK 200 COMPLETION OF THE MODEL. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5.0% ISO-PROPANOL, 20.0% PEG-4000, REMARK 280 0.1M HEPES, PH 7.5, VAPOR DIFFUSION, SITTING DROP, NANODROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.84000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.15500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.15500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 85.26000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.15500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.15500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 28.42000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.15500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.15500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 85.26000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.15500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.15500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 28.42000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 56.84000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 113.68000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 ASP A 2 REMARK 465 ILE A 3 REMARK 465 GLN A 4 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 5 CB CG OD1 ND2 REMARK 470 SER A 34 OG REMARK 470 ASP A 127 OD1 OD2 REMARK 470 GLU A 154 OE1 OE2 REMARK 470 LYS A 157 CE NZ REMARK 470 ARG A 159 CD NE CZ NH1 NH2 REMARK 470 GLU A 233 OE1 OE2 REMARK 470 LYS A 236 CE NZ REMARK 470 ILE A 238 CD1 REMARK 470 LYS A 269 CD CE NZ REMARK 470 ASN A 311 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 84 172.92 -53.78 REMARK 500 GLN A 89 146.72 -171.93 REMARK 500 ASN A 92 17.76 -66.62 REMARK 500 GLU A 126 -126.11 56.32 REMARK 500 MSE A 141 -141.53 60.94 REMARK 500 ASP A 171 72.60 -150.77 REMARK 500 ASP A 232 -169.79 -66.99 REMARK 500 GLU A 252 124.07 -177.61 REMARK 500 CYS A 261 145.47 -172.21 REMARK 500 ASP A 310 -168.83 -71.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE A 309 ASP A 310 139.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 360890 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV REMARK 999 PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE REMARK 999 TARGET SEQUENCE. DBREF 2HAG A 1 311 UNP Q8EIU4 Q8EIU4_SHEON 1 311 SEQADV 2HAG GLY A 0 UNP Q8EIU4 EXPRESSION TAG SEQADV 2HAG MSE A 1 UNP Q8EIU4 MET 1 MODIFIED RESIDUE SEQADV 2HAG MSE A 6 UNP Q8EIU4 MET 6 MODIFIED RESIDUE SEQADV 2HAG MSE A 25 UNP Q8EIU4 MET 25 MODIFIED RESIDUE SEQADV 2HAG MSE A 81 UNP Q8EIU4 MET 81 MODIFIED RESIDUE SEQADV 2HAG MSE A 88 UNP Q8EIU4 MET 88 MODIFIED RESIDUE SEQADV 2HAG MSE A 124 UNP Q8EIU4 MET 124 MODIFIED RESIDUE SEQADV 2HAG MSE A 141 UNP Q8EIU4 MET 141 MODIFIED RESIDUE SEQADV 2HAG MSE A 245 UNP Q8EIU4 MET 245 MODIFIED RESIDUE SEQADV 2HAG MSE A 256 UNP Q8EIU4 MET 256 MODIFIED RESIDUE SEQADV 2HAG MSE A 270 UNP Q8EIU4 MET 270 MODIFIED RESIDUE SEQADV 2HAG MSE A 274 UNP Q8EIU4 MET 274 MODIFIED RESIDUE SEQADV 2HAG MSE A 287 UNP Q8EIU4 MET 287 MODIFIED RESIDUE SEQADV 2HAG MSE A 307 UNP Q8EIU4 MET 307 MODIFIED RESIDUE SEQRES 1 A 312 GLY MSE ASP ILE GLN ASN MSE PRO ARG GLU GLN LEU GLY SEQRES 2 A 312 VAL CYS ALA GLU GLY ASN LEU HIS SER VAL TYR LEU MSE SEQRES 3 A 312 PHE ASN ALA ASN ASP ASN VAL GLU SER GLN LEU ARG PRO SEQRES 4 A 312 CYS ILE ALA ASN VAL ALA GLN TYR ILE TYR GLU LEU THR SEQRES 5 A 312 ASP GLN TYR SER ASP SER ALA PHE ASN GLY PHE VAL ALA SEQRES 6 A 312 ILE GLY ALA ASN TYR TRP ASP SER LEU TYR PRO GLU SER SEQRES 7 A 312 ARG PRO GLU MSE LEU LYS PRO PHE PRO ALA MSE GLN GLU SEQRES 8 A 312 GLY ASN ARG GLU ALA PRO ALA ILE GLU TYR ASP LEU PHE SEQRES 9 A 312 VAL HIS LEU ARG CYS ASP ARG TYR ASP ILE LEU HIS LEU SEQRES 10 A 312 VAL ALA ASN GLU ILE SER GLN MSE PHE GLU ASP LEU VAL SEQRES 11 A 312 GLU LEU VAL GLU GLU GLU ARG GLY PHE ARG PHE MSE ASP SEQRES 12 A 312 SER ARG ASP LEU THR GLY PHE VAL ASP GLY THR GLU ASN SEQRES 13 A 312 PRO LYS GLY ARG HIS ARG GLN GLU VAL ALA LEU VAL GLY SEQRES 14 A 312 SER GLU ASP PRO GLU PHE LYS GLY GLY SER TYR ILE HIS SEQRES 15 A 312 VAL GLN LYS TYR ALA HIS ASN LEU SER LYS TRP HIS ARG SEQRES 16 A 312 LEU PRO LEU LYS LYS GLN GLU ASP ILE ILE GLY ARG THR SEQRES 17 A 312 LYS GLN ASP ASN ILE GLU TYR GLU SER GLU ASP LYS PRO SEQRES 18 A 312 LEU THR SER HIS ILE LYS ARG VAL ASN LEU LYS ASP GLU SEQRES 19 A 312 ASN GLY LYS SER ILE GLU ILE LEU ARG GLN SER MSE PRO SEQRES 20 A 312 TYR GLY SER LEU LYS GLU GLN GLY LEU MSE PHE ILE SER SEQRES 21 A 312 THR CYS ARG THR PRO ASP HIS PHE GLU LYS MSE LEU HIS SEQRES 22 A 312 SER MSE VAL PHE GLY ASP GLY ALA GLY ASN HIS ASP HIS SEQRES 23 A 312 LEU MSE HIS PHE THR SER ALA LEU THR GLY SER SER PHE SEQRES 24 A 312 PHE ALA PRO SER LEU ASP PHE LEU MSE GLN PHE ASP ASN MODRES 2HAG MSE A 6 MET SELENOMETHIONINE MODRES 2HAG MSE A 25 MET SELENOMETHIONINE MODRES 2HAG MSE A 81 MET SELENOMETHIONINE MODRES 2HAG MSE A 88 MET SELENOMETHIONINE MODRES 2HAG MSE A 124 MET SELENOMETHIONINE MODRES 2HAG MSE A 141 MET SELENOMETHIONINE MODRES 2HAG MSE A 245 MET SELENOMETHIONINE MODRES 2HAG MSE A 256 MET SELENOMETHIONINE MODRES 2HAG MSE A 270 MET SELENOMETHIONINE MODRES 2HAG MSE A 274 MET SELENOMETHIONINE MODRES 2HAG MSE A 287 MET SELENOMETHIONINE MODRES 2HAG MSE A 307 MET SELENOMETHIONINE HET MSE A 6 8 HET MSE A 25 8 HET MSE A 81 8 HET MSE A 88 8 HET MSE A 124 8 HET MSE A 141 8 HET MSE A 245 8 HET MSE A 256 8 HET MSE A 270 8 HET MSE A 274 8 HET MSE A 287 8 HET MSE A 307 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 2 HOH *48(H2 O) HELIX 1 1 VAL A 32 TYR A 54 1 23 HELIX 2 2 SER A 55 ALA A 58 5 4 HELIX 3 3 TYR A 69 TYR A 74 1 6 HELIX 4 4 ARG A 110 GLU A 126 1 17 HELIX 5 5 ARG A 159 LEU A 166 1 8 HELIX 6 6 ASP A 171 LYS A 175 5 5 HELIX 7 7 ASN A 188 HIS A 193 1 6 HELIX 8 8 PRO A 196 GLY A 205 1 10 HELIX 9 9 SER A 223 ASN A 229 1 7 HELIX 10 10 PRO A 264 PHE A 276 1 13 HELIX 11 11 ASP A 284 HIS A 288 5 5 HELIX 12 12 SER A 302 GLN A 308 1 7 SHEET 1 A10 LEU A 241 ARG A 242 0 SHEET 2 A10 GLU A 252 CYS A 261 -1 O THR A 260 N LEU A 241 SHEET 3 A10 MSE A 245 SER A 249 -1 N MSE A 245 O MSE A 256 SHEET 4 A10 VAL A 129 PHE A 138 -1 N PHE A 138 O PRO A 246 SHEET 5 A10 HIS A 20 ALA A 28 -1 N MSE A 25 O VAL A 132 SHEET 6 A10 LEU A 102 CYS A 108 -1 O LEU A 106 N VAL A 22 SHEET 7 A10 ASN A 60 GLY A 66 -1 N ASN A 60 O ARG A 107 SHEET 8 A10 THR A 290 ALA A 300 -1 O PHE A 299 N ILE A 65 SHEET 9 A10 SER A 178 HIS A 187 -1 N ALA A 186 O SER A 291 SHEET 10 A10 GLU A 252 CYS A 261 -1 O SER A 259 N HIS A 181 SHEET 1 B 2 MSE A 88 GLU A 90 0 SHEET 2 B 2 ARG A 93 ALA A 95 -1 O ALA A 95 N MSE A 88 SHEET 1 C 2 LEU A 230 LYS A 231 0 SHEET 2 C 2 SER A 237 ILE A 238 -1 O ILE A 238 N LEU A 230 LINK C ASN A 5 N MSE A 6 1555 1555 1.33 LINK C MSE A 6 N PRO A 7 1555 1555 1.34 LINK C LEU A 24 N MSE A 25 1555 1555 1.34 LINK C MSE A 25 N PHE A 26 1555 1555 1.32 LINK C GLU A 80 N MSE A 81 1555 1555 1.32 LINK C MSE A 81 N LEU A 82 1555 1555 1.33 LINK C ALA A 87 N MSE A 88 1555 1555 1.33 LINK C MSE A 88 N GLN A 89 1555 1555 1.33 LINK C GLN A 123 N MSE A 124 1555 1555 1.33 LINK C MSE A 124 N PHE A 125 1555 1555 1.33 LINK C PHE A 140 N MSE A 141 1555 1555 1.33 LINK C MSE A 141 N ASP A 142 1555 1555 1.33 LINK C SER A 244 N MSE A 245 1555 1555 1.33 LINK C MSE A 245 N PRO A 246 1555 1555 1.34 LINK C LEU A 255 N MSE A 256 1555 1555 1.33 LINK C MSE A 256 N PHE A 257 1555 1555 1.32 LINK C LYS A 269 N MSE A 270 1555 1555 1.33 LINK C MSE A 270 N LEU A 271 1555 1555 1.32 LINK C SER A 273 N MSE A 274 1555 1555 1.33 LINK C MSE A 274 N VAL A 275 1555 1555 1.33 LINK C LEU A 286 N MSE A 287 1555 1555 1.33 LINK C MSE A 287 N HIS A 288 1555 1555 1.33 LINK C LEU A 306 N MSE A 307 1555 1555 1.33 LINK C MSE A 307 N GLN A 308 1555 1555 1.32 CRYST1 94.310 94.310 113.680 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010600 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010600 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008800 0.00000